The Value of MR Dacrocystography in Patients with Epiphora | ||
Iraqi Postgraduate Medical Journal | ||
Article 13, Volume 20, Issue 3, July 2021, Pages 292-296 PDF (147.04 K) | ||
DOI: 10.52573/ipmj.2020.169737 | ||
Authors | ||
Hawraa A Abdul Shakoor* 1; Salam M Joori2 | ||
1Oncology Teaching Hospital Medical City Baghdad. | ||
2Ray Institute Baghdad. | ||
Abstract | ||
BACKGROUND: Obstruction or stenosis of the lacrimal ducts, which leads to inadequate drainage of tears, may cause intermittent or constant tearing, which is termed “epiphora, radiological evaluation to the lacrimal gland are divided into anatomical (conventional dacrocystigraphy, CT dacrocystography and MR dacrocystograhy), and functional evaluation (staining test, scintigraphy and dynamic MR dacrocystography). AIM OF STUDY: To study the value of MRI dacrocystography in patients with clinically diagnosed epiphora. METHODS: A total of 36 patients who had presented to the Ophthalmology Clinic from 1st of April 2019 to 1st of October 2019 who were suspected to have obstruction of lacrimal drainage system, were evaluated with MR-DCG after instillation of 0.5% sterile water into the conjunctiva. The examination was performed at MRI department in the X-ray institute in the Medical City, then ophthalmological examination (punctum lavage test) was performed bilaterally for all enrolled patients. RESULTS: Obstruction of lacrimal drainage system was successfully detected in a total of 41 eyes of 36 patients undergoing examination with MR-DCG. The MR-DCG findings of 72 nasolacrimal systems were compared with the ophthalmologic professional diagnosis findings in all patients the sensitivity of MR-DCG was 90.6% for identification of nasolacrimal system obstruction when compared with the ophthalmological professional examination findings, and MR-DCG was found to detect obstruction with high accuracy and provide further information about the level of obstruction and if the obstruction in partial or complete. CONCLUSION: MR-DCG has a high success rate in detection of lacrimal drainage system obstructions and the level and cause of the obstruction, this method avoids both cannulation and ionizing radiation, so could be repeated if necessary, non-time consuming and avoids the side effect of contrast. | ||
Keywords | ||
MRI dacrocystography; epiphora; obstruction; MR-DCG; Iraq | ||
References | ||
10. Song HY, Ahn HS, Park CK, Kwon SH, Kim CS, et al. Complete obstruction of the nasolacrimal system. Part I. Treatment with balloon dilation. Radiology. 1993 Feb;186:367-71.
11. Sasaki T, Nagata Y, Sugiyama K. Nasolacrimal duct obstruction classified by dacryoendoscopy and treated with inferior meatal dacryorhinotomy. Part I: Positional diagnosis of primary nasolacrimal duct obstruction with dacryoendoscope. Am J Ophthalmol 2005; 140:1065-69.
12. Ilgit ET, Yüksel D, Unal M, Akpek S, Isik S, Hasanreisoglu B. Transluminal balloon dilatation of the lacrimal drainage system for the treatment of epiphora. AJR. American journal of roentgenology. 1995;165:1517-24.
13. Linberg JV, Moore CA. Symptoms of canalicular obstruction. Ophthalmology 1988;95: 1077–1079.
14. Clark R. Aparato lacrimal. In: González CF, Becker MH, Flanagan JC, editors. Diagnostico por la imagen en oftalmología. Barcelona: Ediciones Doyma, 1988;77–87.
15. Tucker SM, Linberg JV, Nguyen LL, Viti AJ,Tucker WJ. Measurement of the resistance to fluid flow within the lacrimal outflow system. Ophthalmology 1995;102:
16. Weber AL, Rodriguez-DeVelasquez A, Lucarelli MJ, Cheng HM. Normal anatomy and lesions of the lacrimal sac and duct: evaluated by dacryocystography, computed tomography, and MR imaging. Neuroimaging Clin N Am 1996; 6:199-217.
17. Higashi H, Tamada T, Mizukawa K, Ito K. MR dacryocystography: comparison with dacryoendoscopy in positional diagnosis of nasolacrimal duct obstruction. Radiol Med.2016;121: 580-7.
18. Eldesoky S, Farouk H, Moustafa AN, El-noueam K, Elsabaa A. The role of multi-detector CT dacryocystography in the assessment of naso-lacrimal duct obstruction. The Egyptian Journal of Radiology and Nuclear Medicine. 43: 397-405. 10.1016/j.ejrnm.2012.03.006 - ScienceDirect
19. "Clinical Guidelines for Lacrimal Scintigraphy" (PDF). BNMS. April 2013. Retrieved 23 May 2017.
20. Sagili, Suresh; Selva, Dinesh; Malhotra, Raman (10 April 2012). "Lacrimal Scintigraphy: "Interpretation More Art than Science"". Orbit. 31: 77–85.
21. Caldemeyer KS, Stockberger SM Jr, Broderick LS. Topical contrast-enhanced CT and MR dacryocystography: imaging the lacrimal drainage apparatus of healthy volunteers. AJR Am J Roentgenol 1998;171: 1501-04.
22. Cubuk R, Tasali N, Aydin S, Saydam B, Sengor T. Dynamic MR dacryocystography in patients with epiphora. Eur J Radiol 2010; 73: 230-233.
23. Ramey NA, Hoang JK, Richard MJ. Multidetector CT of nasolacrimal canal morphology: normal variation by age, gender, and race. Ophthal Plast Reconstr Surg. 2013;29:475–80.
24. Amin M, Moseley IF, Rose GE. The value of intubation dacryocystography after dacryocystorhinostomy. Br J Radiol 2000; 73:604–607.
25. Watkins LM, Janfaza P, Rubin PAD. The evolution of endonasal dacryocystorhinostomy. Surv Ophthalmol 2003; 48:73–84.
26. shen GL, Ng JD, Ma XP. Etiology, diagnosis, management and outcomes of epiphora referrals to an oculoplastic practice. (2016) International journal of ophthalmology. 9: 1751-55. doi:10.18240/ijo.2016.12.08 – Pubmed
27. Manfre L, de Maria M, Todaro E, Mangiameli A, Ponte F, Lagalla R. MR dacryocystography: comparison with dacryocystography and CT dacryocystography. AJNR Am J Neuroradiol 2000; 21: 1145-50.
28. Takehara Y, Isoda H, Kurihashi K, Isogai S, Kodaira N, Masunaga H et al, Nozaki A, Sakahara H. Dynamic MR dacryocystography: a new method for evaluating nasolacrimal duct obstructions. AJR Am J Roentgenol 2000; 175: 469-473.
29. Hoffmann KT, Hosten N, Anders N, Stroszczynski C, Liebig T, Hartmann C, et al High-resolution conjunctival contrast-enhanced MRI dacryocystography. Neuroradiology. 1999;41:208-13.
30. Kim N, Park C, Park DJ, Kim HH, Kim S, Kim YJ et al. Lacrimal drainage obstruction in gastric cancer patients receiving S-1 chemotherapy. Ann Oncol. 2012;23:2065-71. | ||
Statistics Article View: 71 PDF Download: 85 |